Journal article icon

Journal article

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial.

Abstract:

OBJECTIVE: Circulating levels of soluble receptor for advanced glycation end products (sRAGE) likely comprise both a secreted isoform (esRAGE) and wild-type RAGE cleaved from the cell membrane. Both sRAGE and esRAGE have been proposed as biomarkers of cardiovascular disease (CVD), but prospective data are limited. We examined the relationship of sRAGE and esRAGE to incident coronary heart disease (CHD) and stroke in type 2 diabetic patients followed for 3.9 years in a trial of atorvastatin: ...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2337/db11-0291

Authors


Expand authors...
Journal:
Diabetes
Volume:
60
Issue:
9
Pages:
2379-2385
Publication date:
2011-09-01
DOI:
EISSN:
1939-327X
ISSN:
0012-1797
Source identifiers:
177298
Language:
English
Keywords:
Pubs id:
pubs:177298
UUID:
uuid:c67686ff-c4ea-499f-bd8f-e1a1ec43b5cd
Local pid:
pubs:177298
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP